Charles River Laboratories International Inc (NYSE:CRL)
$ 214.2 25.52 (13.53%) Market Cap: 10.95 Bil Enterprise Value: 13.50 Bil PE Ratio: 25.59 PB Ratio: 2.97 GF Score: 87/100

Charles River Laboratories International Inc at Evercore HealthCONx Conference Transcript

Dec 04, 2019 / 02:30PM GMT
Release Date Price: $145.39 (+1.15%)
Elizabeth Hammell Anderson
Evercore ISI Institutional Equities, Research Division - Associate

All right. So I think we'll get started. Hi, everybody. Good morning. Welcome. I'm Elizabeth Anderson. I'm the healthcare tech and distribution analyst at Evercore ISI, and I am joined by the illustrious Jim Foster, CEO of Charles River.

So the way I was thinking about doing this, I have a bunch of questions, but if you have questions, you can feel free to interject, and we'll go from there.

All right. Well, thank you. Welcome.

James C. Foster
Charles River Laboratories International, Inc. - Chairman, CEO & President

Nice to be here.

Questions & Answers

Elizabeth Hammell Anderson
Evercore ISI Institutional Equities, Research Division - Associate

So as I get started, I will start off with the obligatory biotech funding question, which I'm sure you could probably answer in your sleep at this time. But sort of what leading indicators do you look at as you sort of monitor biotech funding? I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot